Search All News
Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
Seventy-five percent of patients with an autoimmune disease that causes hair loss had significant hair regrowth after treatment with ruxolitinib.
Interdisciplinary dermatology research is helping advance understanding of conditions like alopecia areata, epidermolysis bullosa, and skin cancer.
- August 17, 2014
Columbia researchers identify immune cells responsible for destroying hair follicles in people with alopecia areata and restore hair growth with an FDA-approved drug
- June 25, 2014
During a U.S. News Twitter chat on #SunHealth, Dr. Larisa Geskin offered expert advice on sunscreen, sunglasses, and more.
- May 16, 2014
People diagnosed with celiac disease are not at increased risk of melanoma, researchers at CUMC and Karolinska Institutet have found.
- April 6, 2014
Columbia scientists reveal how touch cells just beneath the skin's surface create our ability to feel fine details and texture.
- December 13, 2013
Tips for avoiding dry, flaky skin during the winter.
- October 21, 2013
Researchers at Columbia University Medical Center have devised a hair restoration method that can generate new human hair growth, rather than simply redistribute hair from one part of the scalp to another.
- June 30, 2010
Among the most common forms of hair loss, and perhaps the most common autoimmune disease, alopecia areata affects 5.3 million in U.S.
- April 14, 2010
- June 3, 2008